Cann Group (ASX:CAN) Cash, Cash Equivalents, Marketable Securities : A$1.64 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Cann Group Cash, Cash Equivalents, Marketable Securities?

Cann Group's quarterly cash, cash equivalents, marketable securities declined from Dec. 2022 (A$7.19 Mil) to Jun. 2023 (A$0.77 Mil) but then increased from Jun. 2023 (A$0.77 Mil) to Dec. 2023 (A$1.64 Mil).

Cann Group's annual cash, cash equivalents, marketable securities declined from Jun. 2021 (A$3.11 Mil) to Jun. 2022 (A$1.91 Mil) and declined from Jun. 2022 (A$1.91 Mil) to Jun. 2023 (A$0.77 Mil).

Cann Group Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Cann Group's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cann Group Cash, Cash Equivalents, Marketable Securities Chart

Cann Group Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

46.39

1.55

3.11

1.91

0.77

Cann Group Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial									10.68	1.91	7.19	0.77	1.64

Cann Group Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Cann Group (ASX:CAN) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Cann Group Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Cann Group's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cann Group (ASX:CAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cann Group Ltd (ASX:CAN) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

CNGGF:USA CVJ:Germany

Address

262-276 Lorimer Street, Port Melbourne, VIC, AUS, 3207

Website

https://www.canngrouplimited.com

Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.